A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2002
12/05/2002	DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases
12/05/2002	CA2459176A1 Oral composition comprising an extract from the bark of albizzia myriophylla
12/05/2002	CA2449245A1 Small molecule antagonists of bcl2 family proteins
12/05/2002	CA2449173A1 An arylation method for the functionalization of o-allyl erythromycin derivatives
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2449026A1 Use of polyclonal immunoglobulins
12/05/2002	CA2449014A1 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
12/05/2002	CA2449000A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	CA2448963A1 Pharmaceutical use for secreted bacterial effector proteins
12/05/2002	CA2448891A1 Long lasting fusion peptide inhibitors for hiv infection
12/05/2002	CA2448637A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	CA2448620A1 Vaccination against the feline immunodeficiency virus
12/05/2002	CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	CA2448438A1 Soft elastic capsules comprising ritonavir and/or lopinavir
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/05/2002	CA2448345A1 Stable liquid formulations of antibodies
12/05/2002	CA2448248A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	CA2448198A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448104A1 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2447662A1 Transporters and ion channels
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2446723A1 Antibodies that immunospecifically bind to trail receptors
12/05/2002	CA2446697A1 Antibacterial agents
12/05/2002	CA2432187A1 Daptomycin and related analogs in crystalline form
12/05/2002	CA2411549A1 Ligands of integrin receptors
12/05/2002	CA2411082A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
12/04/2002	EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002	EP1262186A1 Azalide antibiotic compositions
12/04/2002	EP1262185A1 Synergistic antibiotic compositions
12/04/2002	EP1262184A1 Compositions comprising S-tofisopam and use of these compositions for the preparation of a medicament for the treatment or prevention of convulsions or seizures
12/04/2002	EP1262183A1 Use of norastemizole for the treatment of allergic rhinitis
12/04/2002	EP1262181A1 Urease inhibitors
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261694A2 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261631A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
12/04/2002	EP1261629A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
12/04/2002	EP1261625A2 Memno peptides, a process for their preparation and their use
12/04/2002	EP1261611A2 Inhibitors of hepatitis c virus ns3 protease
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
12/04/2002	EP1261603A1 Flavone derivatives, preparation method and use as medicines
12/04/2002	EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002	EP1261587A1 Stilbene derivatives, their preparation and their use as antiviral agents
12/04/2002	EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261377A2 Immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261366A1 Adjuvant treatment by in vivo activation of dendritic cells
12/04/2002	EP1261362A2 Novel amino acid and peptide inhibitors of staphylococcus virulence
12/04/2002	EP1261360A1 Casein derived peptides and uses thereof in therapy
12/04/2002	EP1261357A1 Isolation and transplantation of retinal stem cells
12/04/2002	EP1261355A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/04/2002	EP1261353A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
12/04/2002	EP1261352A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
12/04/2002	EP1261351A2 Nystatin formulation having reduced toxicity
12/04/2002	EP1261339A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1261323A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists
12/04/2002	EP1261320A2 Micellar pharmaceutical compositions for buccal and pulmonary application
12/04/2002	EP1261259A1 Treatment of infection in animals
12/04/2002	EP1143805B1 Method for reducing incidence of ascites in poultry by aid of natamycin
12/04/2002	EP1058683B1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/04/2002	EP1005342B1 Pharmaceutical compositions of tizoxanide and nitazoxanide
12/04/2002	EP0971961B1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/04/2002	EP0938298B1 Liposome-based composition
12/04/2002	EP0912561B1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
12/04/2002	EP0863890B1 5-amidomethyl alpha, betha-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents
12/04/2002	EP0824358B1 Acellular pertussis vaccines and methods of preparation thereof
12/04/2002	EP0815124B1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/04/2002	EP0765662B1 Use of 5,6-o-benzylidene-l-ascorbic acid or salts thereof for the manufacture of a medicament for the treatment of hiv
12/04/2002	EP0719285B1 Il8 inhibitors
12/04/2002	EP0693937B1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
12/04/2002	EP0650356B1 Rapamycin derivatives
12/04/2002	EP0638092B1 Synthetic peptide vaccines for dental caries
12/04/2002	CN1383428A Medicinal compsns. having antiplasmid effect and its prepn. method
12/04/2002	CN1383384A Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis B surface antigen, and prepn. method thereof
12/04/2002	CN1383375A Treatment of human herpesviruses using hyperthermia
12/04/2002	CN1382477A Chinese medicine for treating AIDS
12/04/2002	CN1382452A Process for preparing medicinal pill able to kill spiroplasmavirus
12/04/2002	CN1095362C Bath lotion contg. total alkaloid of sophora alopecuroide
12/03/2002	WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
12/03/2002	US6489478 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
12/03/2002	US6489464 Branched oligonucleotides as pathogen-inhibitory agents
12/03/2002	US6489440 Aerothricins for the preparation of medicaments with antifunal properties
12/03/2002	US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002	US6489358 Pharmaceutical compositions containing mupirocin
12/03/2002	US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489338 Imidazopyridine and imidazopyrimidine antiviral agents
12/03/2002	US6489330 Or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of such as famciclovir; prophylactic treatment for kaposi's sarcoma or aids related disease

1 ... 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 ... 1798